Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 35 for:    Lanreotide | Neuroendocrine Tumors

Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg (CLARINET FORTE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02651987
Recruitment Status : Active, not recruiting
First Posted : January 11, 2016
Last Update Posted : May 31, 2019
Sponsor:
Information provided by (Responsible Party):
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2019